16-50699832-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001370466.1(NOD2):​c.337G>A​(p.Ala113Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0012 in 1,613,572 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0067 ( 8 hom., cov: 32)
Exomes 𝑓: 0.00063 ( 9 hom. )

Consequence

NOD2
NM_001370466.1 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.55
Variant links:
Genes affected
NOD2 (HGNC:5331): (nucleotide binding oligomerization domain containing 2) This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032271743).
BP6
Variant 16-50699832-G-A is Benign according to our data. Variant chr16-50699832-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 462700.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-50699832-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00667 (1016/152326) while in subpopulation AFR AF= 0.023 (955/41566). AF 95% confidence interval is 0.0218. There are 8 homozygotes in gnomad4. There are 495 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NOD2NM_001370466.1 linkuse as main transcriptc.337G>A p.Ala113Thr missense_variant 2/12 ENST00000647318.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NOD2ENST00000647318.2 linkuse as main transcriptc.337G>A p.Ala113Thr missense_variant 2/12 NM_001370466.1 P1Q9HC29-2

Frequencies

GnomAD3 genomes
AF:
0.00668
AC:
1016
AN:
152208
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0230
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00335
GnomAD3 exomes
AF:
0.00174
AC:
436
AN:
250802
Hom.:
1
AF XY:
0.00131
AC XY:
178
AN XY:
135588
show subpopulations
Gnomad AFR exome
AF:
0.0237
Gnomad AMR exome
AF:
0.00119
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.000630
AC:
920
AN:
1461246
Hom.:
9
Cov.:
33
AF XY:
0.000523
AC XY:
380
AN XY:
726902
show subpopulations
Gnomad4 AFR exome
AF:
0.0232
Gnomad4 AMR exome
AF:
0.00116
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000630
Gnomad4 OTH exome
AF:
0.00134
GnomAD4 genome
AF:
0.00667
AC:
1016
AN:
152326
Hom.:
8
Cov.:
32
AF XY:
0.00665
AC XY:
495
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.0230
Gnomad4 AMR
AF:
0.00327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00332
Alfa
AF:
0.00337
Hom.:
0
Bravo
AF:
0.00805
ESP6500AA
AF:
0.0212
AC:
93
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00198
AC:
240
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJan 24, 2019- -
Regional enteritis;C5201146:Blau syndrome Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 22, 2024- -
Autoinflammatory syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenApr 04, 2022- -
Inflammatory bowel disease 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaOct 18, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Blau syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaOct 18, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.11
.;.;T
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.23
N
LIST_S2
Uncertain
0.86
D;D;D
MetaRNN
Benign
0.0032
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
.;.;L
MutationTaster
Benign
0.89
N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.3
.;N;N
REVEL
Benign
0.038
Sift
Benign
0.29
.;T;T
Sift4G
Benign
0.17
.;T;T
Polyphen
0.37
.;.;B
Vest4
0.16
MVP
0.60
MPC
0.12
ClinPred
0.023
T
GERP RS
4.3
Varity_R
0.10
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34684955; hg19: chr16-50733743; COSMIC: COSV99039077; API